Alachua, FL (PRWEB) January 10, 2013
AxoGen, Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today that studies based on clinical use of Avance® Nerve Graft will be presented at the 2013 Annual Meeting of the American Association for Hand Surgery, January 9-12 in Naples, FL. The two studies being presented will report on findings from the RANGER® Registry, an on-going multicenter utilization and outcomes study for Avance® Nerve Graft, a processed nerve allograft for the repair and reconstruction of peripheral nerve segmental defects.
Results from the study, “Recovery Outcomes of Short Gap Sensory Nerve Repairs with Processed Nerve Allografts from Multicenter Registry Study,” will be presented by Brian Rinker, MD, a hand surgeon from the University of Kentucky and an investigator for the RANGER® Registry, on January 11 in Naples, FL. The presentation will report on repairs for 15 subjects with 17 digital nerve injuries with gaps ranging from 5-15 mm in length.
Results from the study, “The Second Data Milestone of an Expanded Enrollment from an Ongoing Multicenter Registry Study on the Use of Processed Nerve Allograft for Sensory, Mixed, and Motor Nerve Reconstructions,” will be presented as a poster by Bauback Safa, MD of The Buncke Clinic and an investigator for the RANGER® Registry. This analysis includes outcomes from 74 repairs on sensory, motor and mixed nerves with gaps of 5 – 50 mm.
“Clinical data to support the use of Avance® Nerve Graft continues to grow,” says Erick DeVinney, Director of Clinical and Translational Science for AxoGen. “We are excited to have additional clinical data provided by experts in the field of peripheral nerve repair.”
Avance® Nerve Graft is proces
Copyright©2012 Vocus, Inc.
All rights reserved